Despite Data Concerns, Panel Recommends First-In-Class Toe Implant
This article was originally published in The Gray Sheet
Executive Summary
Cartiva, a toe implant to treat osteoarthritis, received a strong recommendation from a panel of FDA experts despite suggestions that the device had not fully proven itself.